AQR Arbitrage’s AEON Biopharma Inc AEON.WS Stock Holding History

AQR Arbitrage’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50,000	Closed	-$4.5K	–	860
2023 Q2	$4.5K	Hold	50,000	–	–	﹤0.01%	804
2023 Q1	$2.75K	Hold	50,000	–	–	﹤0.01%	1000
2022 Q4	$2.28K	Hold	50,000	–	–	﹤0.01%	1112
2022 Q3	$3K	Hold	50,000	–	–	﹤0.01%	1311
2022 Q2	$8K	Hold	50,000	–	–	﹤0.01%	1268
2022 Q1	$15K	Hold	50,000	–	–	﹤0.01%	1180
2021 Q4	$486K	Hold	50,000	–	–	0.01%	908
2021 Q3	$31K	Hold	50,000	–	–	﹤0.01%	1009
2021 Q2	$50K	Buy	+50,000	New	+$38K	﹤0.01%	947

Other funds holding AEON.WS

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AQR Arbitrage's AEON.WS Position: Q3 2023 in Review

AQR Arbitrage sold out of AEON Biopharma Inc (AEON.WS) in Q3 2023, closing a stake of 50,000 shares — an estimated $4.5K sold.

AQR Arbitrage first reported a position in AEON.WS in Q2 2021 and held it in 9 quarters. The position peaked at $486K in Q4 2021. 40 funds tracked by Wall St. Rank hold AEON.WS as of Q3 2023.

AQR Arbitrage reported no remaining AEON Biopharma Inc position as of Q3 2023 after selling out during the quarter.
AQR Arbitrage sold 50,000 AEON Biopharma Inc shares in Q3 2023, an estimated $4.5K.
AQR Arbitrage first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 9 quarters.
AQR Arbitrage's AEON Biopharma Inc position peaked at $486K in Q4 2021.
40 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q3 2023.

Based on AQR Arbitrage's 13F filing for Q3 2023, filed 14 Nov 2023.